-
公开(公告)号：US10888541B2
公开(公告)日：2021-01-12
申请号：US16423225
申请日：2019-05-28
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/00 , A61K31/4422 , A61K31/5415 , A61K31/554
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US20210128514A1
公开(公告)日：2021-05-06
申请号：US17146010
申请日：2021-01-11
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/00 , A61K31/4422 , A61K31/5415 , A61K31/554
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, of calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier, and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US20230233506A1
公开(公告)日：2023-07-27
申请号：US18114305
申请日：2023-02-27
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/4422 , A61K31/5415 , A61K31/00 , A61K31/554
CPC分类号： A61K31/277 , A61K31/00 , A61K31/554 , A61K31/4422 , A61K31/5415
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeatic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of vital protein transistion, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolic thereof, a calmodulin blocker and a metabolite thereof, and a plumaceutical acceptable diluent or carrier: and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US20190274992A1
公开(公告)日：2019-09-12
申请号：US16423225
申请日：2019-05-28
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/554 , A61K31/00 , A61K31/4422 , A61K31/5415
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
